InsiderTrades.com logo
Russell Schundler net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Russell Schundler Biography and Net Worth

General Counsel of Liquidia
Mr. Schundler serves as general counsel and corporate secretary. From 2014 to 2021, Mr. Schundler served as general counsel at PBM Capital Group, a healthcare investment firm, where he managed all legal matters for PBM and its subsidiaries. Prior to PBM, Mr. Schundler was a corporate attorney with the law firms of Woods Rogers PLC and McGuireWoods LLP from 2001 to 2014, where he specialized in mergers and acquisitions, corporate financings and general corporate matters. Mr. Schundler also served from 2011 to 2014 as adjunct faculty at the University of Virginia School of Law, where he oversaw the Transactional Law Clinic. Mr. Schundler is a member of the Virginia bar and holds a B.A. in history and economics from the University of Virginia and a J.D. from the University of Virginia School of Law.

What is Russell Schundler's net worth?

The estimated net worth of Russell Schundler is at least $8.94 million as of January 14th, 2025. Mr. Schundler owns 573,478 shares of Liquidia stock worth more than $8,942,816 as of March 25th. This net worth evaluation does not reflect any other investments that Mr. Schundler may own. Additionally, Mr. Schundler receives an annual salary of $778,490.00 as General Counsel at Liquidia. Learn More about Russell Schundler's net worth.

How old is Russell Schundler?

Mr. Schundler is currently 49 years old. There are 5 older executives and no younger executives at Liquidia. The oldest executive at Liquidia is Dr. Roger A. Jeffs Ph.D., CEO & Director, who is 62 years old. Learn More on Russell Schundler's age.

What is Russell Schundler's salary?

As the General Counsel of Liquidia Co., Mr. Schundler earns $778,490.00 per year. There are 2 executives that earn more than Mr. Schundler. The highest earning executive at Liquidia is Dr. Roger A. Jeffs Ph.D., CEO & Director, who commands a salary of $1,320,000.00 per year. Learn More on Russell Schundler's salary.

How do I contact Russell Schundler?

The corporate mailing address for Mr. Schundler and other Liquidia executives is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. Liquidia can also be reached via phone at (919) 328-4400 and via email at ir@liquidia.com. Learn More on Russell Schundler's contact information.

Has Russell Schundler been buying or selling shares of Liquidia?

Over the course of the past ninety days, Russell Schundler has sold $193,109.54 of Liquidia stock. Most recently, Russell Schundler sold 16,393 shares of the business's stock in a transaction on Tuesday, January 14th. The shares were sold at an average price of $11.78, for a transaction totalling $193,109.54. Following the completion of the sale, the general counsel now directly owns 573,478 shares of the company's stock, valued at $6,755,570.84. Learn More on Russell Schundler's trading history.

Who are Liquidia's active insiders?

Liquidia's insider roster includes Jason Adair (Chief Business Officer), Roger Jeffs (CEO), Michael Kaseta (CFO), Arthur Kirsch (Director), Paul Manning (Director), Scott Moomaw (Chief Commercial Officer), Rajeev Saggar (Insider), and Russell Schundler (General Counsel). Learn More on Liquidia's active insiders.

Are insiders buying or selling shares of Liquidia?

In the last year, Liquidia insiders bought shares 1 times. They purchased a total of 150,000 shares worth more than $1,426,500.00. In the last year, insiders at the sold shares 31 times. They sold a total of 133,327 shares worth more than $1,616,512.79. The most recent insider tranaction occured on January, 27th when insider Jason Adair sold 445 shares worth more than $6,319.00. Insiders at Liquidia own 30.1% of the company. Learn More about insider trades at Liquidia.

Information on this page was last updated on 1/27/2025.

Russell Schundler Insider Trading History at Liquidia

See Full Table

Russell Schundler Buying and Selling Activity at Liquidia

This chart shows Russell Schundler's buying and selling at Liquidia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$193ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100k$0$100kTotal Insider BuyingTotal Insider Selling

Liquidia Company Overview

Liquidia logo
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $15.60
Low: $15.47
High: $15.77

50 Day Range

MA: $14.87
Low: $11.36
High: $16.52

2 Week Range

Now: $15.60
Low: $8.26
High: $16.92

Volume

676,229 shs

Average Volume

933,973 shs

Market Capitalization

$1.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.07